Kim Kyuseok, Shin Jung Ho, Lee Jae Hyuk, Jo You Hwan, Kim Min A, Lee Kyoungbun, Kang Kyeong Won, Hong Yun-Sik
From the Department of Emergency Medicine (K.K., J.H.L., Y.H.J.), Seoul National University Bundang Hospital; and Department of Emergency Medicine (J.H.S.), Korean Armed Forces Capital Hospital, Gyeonggi-do; Department of Pathology (M.A.K., K.L.), Seoul National University Hospital; and Department of Emergency Medicine (Y.-S.H.), Korea University Medical Center, Seoul; and Department of Emergency Medicine (K.W.K.), Jeju National University Hospital, Jeju-do, Korea.
J Trauma Acute Care Surg. 2015 Feb;78(2):370-7. doi: 10.1097/TA.0000000000000511.
The inhibition of mitochondrial permeability transition pore opening during ischemia-reperfusion can ameliorate injuries. This study aimed to investigate the effects of cyclosporine A (CsA) in rats after hemorrhagic shock.
Male Sprague-Dawley rats were subjected to pressure-controlled hemorrhagic shock (mean arterial pressure, 38 ± 1 mm Hg) for 90 minutes. After the hemorrhagic shock period, rats were randomly allocated to one of three groups as follows: a control group, a CsA10 group, or a CsA50 group. CsA for the treatment groups (10 mg/kg for the CsA10 group and 50 mg/kg for the CsA50 group) or normal saline for the control group was administered via tail vein for 10 minutes, and shed blood was transfused for 15 minutes. For the survival study, animals were observed for up to 9 hours, and their survival time was recorded until death. Separate experiments were performed to examine the effect of CsA on inflammatory responses and liver injury. Rats were sacrificed at 210 minutes after the shock period, and blood and liver tissues were harvested.
Survival times were shown to be significantly longer in the CsA-treated groups (i.e., the CsA10 and CsA50 groups) than in the control group. Plasma interleukin-6 and thiobarbituric acid-reactive substances were significantly lower in the CsA50 group than in the control group and phosphorylation of Akt, GSK-3β, and Bad were significantly increased in the CsA-treated groups compared with the control group. Expressions of Bcl-2, cleaved caspase 3, and cytoplasmic cytochrome C were significantly decreased in the CsA-treated groups compared with the control group. Although histologic liver injury was not significantly different among the groups, ultrastructural changes of mitochondria were more prominent in the control group than in the CsA-treated groups.
CsA increased survival time, decreased proinflammatory cytokine and lipid peroxidation, and augmented Akt survival pathways in rats subjected to pressure-controlled hemorrhagic shock.
在缺血再灌注期间抑制线粒体通透性转换孔开放可改善损伤。本研究旨在探讨环孢素A(CsA)对失血性休克大鼠的影响。
雄性Sprague-Dawley大鼠接受压力控制的失血性休克(平均动脉压,38±1 mmHg)90分钟。失血性休克期后,大鼠被随机分为以下三组之一:对照组、CsA10组或CsA50组。治疗组(CsA10组为10 mg/kg,CsA50组为50 mg/kg)给予CsA或对照组给予生理盐水,经尾静脉给药10分钟,然后回输 shed blood 15分钟。在生存研究中,观察动物长达9小时,并记录其存活时间直至死亡。进行单独实验以检查CsA对炎症反应和肝损伤的影响。在休克期后210分钟处死大鼠,采集血液和肝脏组织。
CsA治疗组(即CsA10组和CsA50组)的存活时间明显长于对照组。CsA50组血浆白细胞介素-6和硫代巴比妥酸反应性物质明显低于对照组,与对照组相比,CsA治疗组中Akt、GSK-3β和Bad的磷酸化明显增加。与对照组相比,CsA治疗组中Bcl-2、裂解的半胱天冬酶3和细胞质细胞色素C的表达明显降低。尽管各组间组织学肝损伤无明显差异,但对照组线粒体的超微结构变化比CsA治疗组更明显。
CsA可延长压力控制失血性休克大鼠的存活时间,降低促炎细胞因子和脂质过氧化,并增强Akt存活途径。